 SAN DIEGO, Aug. 09, 2021 GLOBE NEWSWIRE -- Longboard Pharmaceuticals, Inc. Nasdaq: LBPH, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021. 